Fibroblast growth factor 21 and fructose dynamics in humans.

Published online

Journal Article

Objective: Fructose consumption is a risk factor for metabolic disease. We recently demonstrated that fibroblast growth factor 21 (FGF21), a metabolic hormone involved in lipid and glucose metabolism, is acutely stimulated in humans by 75 g oral fructose, with peak levels occurring 2 h after consumption. This study reports on the dose dependency and reproducibility of the FGF21 response to fructose. Methods: Lean, healthy adults drank either five different doses of fructose dissolved in water, each separated by 2 weeks, or the same dose on three occasions, each separated by 1 week. Results: Fibroblast growth factor 21 levels peaked at 2 h in a dose-dependent manner. No significant increase in FGF21 was seen after consumption of 10 g fructose, while robust increases were seen after drinking solutions containing 30, 50 and 75 g. At 2 h, the minimal fold change of FGF21 was highest following a 75 g fructose drink, and all subjects demonstrated at least a doubling of FGF21 levels following consumption of this dose. Conclusions: The increase in FGF21 following an oral fructose challenge is dose dependent, with levels peaking at 2 h independent of dose. The FGF21 response to 75 g fructose is also highly reproducible within individuals. Clinical Implications: By demonstrating that the FGF21 response to fructose is dose dependent and reproducible, this study deepens current understanding of FGF21 fructose dynamics and physiology in humans. This is an important area of clinical interest given associations between fructose intake and a wide variety of metabolic derangements.

Full Text

Duke Authors

Cited Authors

  • Migdal, A; Comte, S; Rodgers, M; Heineman, B; Maratos-Flier, E; Herman, M; Dushay, J

Published Date

  • October 2018

Published In

Volume / Issue

  • 4 / 5

Start / End Page

  • 483 - 489

PubMed ID

  • 30338119

Pubmed Central ID

  • 30338119

Electronic International Standard Serial Number (EISSN)

  • 2055-2238

Digital Object Identifier (DOI)

  • 10.1002/osp4.295


  • eng

Conference Location

  • United States